BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22786763)

  • 21. Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival.
    Roos P; Johannsen P; Lindquist SG; Brown JM; Waldemar G; Duno M; Nielsen TT; Budtz-Jørgensen E; Gydesen S; Holm IE; Collinge J; Isaacs AM; ; Nielsen JE
    Acta Neurol Scand; 2022 May; 145(5):529-540. PubMed ID: 34997757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The functional analysis of the CHMP2B missense mutation associated with neurodegenerative diseases in the endo-lysosomal pathway.
    Han JH; Ryu HH; Jun MH; Jang DJ; Lee JA
    Biochem Biophys Res Commun; 2012 May; 421(3):544-9. PubMed ID: 22521643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
    Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
    Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene.
    Holm IE; Isaacs AM; Mackenzie IR
    Acta Neuropathol; 2009 Nov; 118(5):719-20. PubMed ID: 19844732
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulation of postsynaptic function by the dementia-related ESCRT-III subunit CHMP2B.
    Chassefeyre R; Martínez-Hernández J; Bertaso F; Bouquier N; Blot B; Laporte M; Fraboulet S; Couté Y; Devoy A; Isaacs AM; Pernet-Gallay K; Sadoul R; Fagni L; Goldberg Y
    J Neurosci; 2015 Feb; 35(7):3155-73. PubMed ID: 25698751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory markers of CHMP2B-mediated frontotemporal dementia.
    Roos P; von Essen MR; Nielsen TT; Johannsen P; Stokholm J; Bie AS; Waldemar G; Simonsen AH; Heslegrave A; Zetterberg H; ; Sellebjerg F; Nielsen JE
    J Neuroimmunol; 2018 Nov; 324():136-142. PubMed ID: 30193769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ik2/TBK1 and Hook/Dynein, an adaptor complex for early endosome transport, are genetic modifiers of FTD-associated mutant CHMP2B toxicity in Drosophila.
    Lu Y; West RJH; Pons M; Sweeney ST; Gao FB
    Sci Rep; 2020 Aug; 10(1):14221. PubMed ID: 32848189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic screen identifies serpin5 as a regulator of the toll pathway and CHMP2B toxicity associated with frontotemporal dementia.
    Ahmad ST; Sweeney ST; Lee JA; Sweeney NT; Gao FB
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12168-73. PubMed ID: 19581577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of CHMP2B in frontotemporal dementia.
    Urwin H; Ghazi-Noori S; Collinge J; Isaacs A
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):208-12. PubMed ID: 19143633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3.
    Chandrasekaran A; Dittlau KS; Corsi GI; Haukedal H; Doncheva NT; Ramakrishna S; Ambardar S; Salcedo C; Schmidt SI; Zhang Y; Cirera S; Pihl M; Schmid B; Nielsen TT; Nielsen JE; Kolko M; Kobolák J; Dinnyés A; Hyttel P; Palakodeti D; Gorodkin J; Muddashetty RS; Meyer M; Aldana BI; Freude KK
    Stem Cell Reports; 2021 Nov; 16(11):2736-2751. PubMed ID: 34678206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice.
    Ghazi-Noori S; Froud KE; Mizielinska S; Powell C; Smidak M; Fernandez de Marco M; O'Malley C; Farmer M; Parkinson N; Fisher EM; Asante EA; Brandner S; Collinge J; Isaacs AM
    Brain; 2012 Mar; 135(Pt 3):819-32. PubMed ID: 22366797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
    Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
    Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
    Toft A; Roos P; Jääskeläinen O; Musaeus CS; Henriksen EE; Johannsen P; Nielsen TT; Herukka SK; Hviid Simonsen A; Nielsen JE
    Dement Geriatr Cogn Disord; 2020; 49(6):533-538. PubMed ID: 33626531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).
    Rostgaard N; Roos P; Budtz-Jørgensen E; Johannsen P; Waldemar G; Nørremølle A; Lindquist SG; Gydesen S; Brown JM; Collinge J; Isaacs AM; ; Nielsen TT; Nielsen JE
    Neurobiol Aging; 2017 Nov; 59():221.e1-221.e7. PubMed ID: 28888721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rab8, POSH, and TAK1 regulate synaptic growth in a Drosophila model of frontotemporal dementia.
    West RJ; Lu Y; Marie B; Gao FB; Sweeney ST
    J Cell Biol; 2015 Mar; 208(7):931-47. PubMed ID: 25800055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel missense mutation in charged multivesicular body protein 2B in a patient with frontotemporal dementia.
    Ferrari R; Kapogiannis D; Huey ED; Grafman J; Hardy J; Momeni P
    Alzheimer Dis Assoc Disord; 2010; 24(4):397-401. PubMed ID: 20592581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Charged multivesicular body protein 2B (CHMP2B) of the endosomal sorting complex required for transport-III (ESCRT-III) polymerizes into helical structures deforming the plasma membrane.
    Bodon G; Chassefeyre R; Pernet-Gallay K; Martinelli N; Effantin G; Hulsik DL; Belly A; Goldberg Y; Chatellard-Causse C; Blot B; Schoehn G; Weissenhorn W; Sadoul R
    J Biol Chem; 2011 Nov; 286(46):40276-86. PubMed ID: 21926173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ESCRT, autophagy, and frontotemporal dementia.
    Lee JA; Gao FB
    BMB Rep; 2008 Dec; 41(12):827-32. PubMed ID: 19123971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus.
    Yamazaki Y; Takahashi T; Hiji M; Kurashige T; Izumi Y; Yamawaki T; Matsumoto M
    Neurosci Lett; 2010 Jun; 477(2):86-90. PubMed ID: 20420883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA Interference-Mediated Inhibition of ESCRT in Mammalian Cells.
    Bowers K
    Methods Mol Biol; 2019; 1998():305-318. PubMed ID: 31250311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.